Advertisement
Screener

cbdMD, Inc. (YCBD) Overview

cbdMD, Inc. (YCBD) Overview

  • 1 Apr 2024: Period ending 30 Jun 2024; Estimate (m); Actual -0.15; Beat / miss (m).
  • 1 Jan 2024: Period ending 31 Mar 2024; Estimate (m); Actual -1.35; Beat / miss (m).
  • 1 Apr 2023: Period ending 30 Jun 2023; Estimate (m); Actual -1.16; Beat / miss (m).
  • 1 Jan 2023: Period ending 31 Mar 2023; Estimate (m); Actual -1.74; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.42$0.59$0.84$1.19$1.68$2.382025-09-292026-09-29$0.42$1.90$8.59$38.97$176.72$801.362021-09-292026-09-29$0.42$2.39$13.68$78.22$447.40$2,559.062017-11-172026-09-29$0.42$2.39$13.68$78.22$447.40$2,559.062017-11-172026-09-29$0.42$2.39$13.68$78.22$447.40$2,559.062017-11-172026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$0.47
Previous close
$0.46
Change
$0.00
Change (%)
1.08%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

YCBD
-65.05%
S&P 500
(m)

1 year

YCBD
-65.81%
S&P 500
(m)

3 years

YCBD
-94.30%
S&P 500
(m)

5 years

YCBD
-99.93%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2024 ○ Estimate (m) ● Actual -0.15

-1.82-1.34-0.86-0.380.1031 Dec 2022: estimate (m); actual -0.0831 Dec 2022(m)31 Mar 2023: estimate (m); actual -1.7431 Mar 2023(m)30 Jun 2023: estimate (m); actual -1.1630 Jun 2023(m)31 Mar 2024: estimate (m); actual -1.3531 Mar 2024(m)30 Jun 2024: estimate (m); actual -0.1530 Jun 2024(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202430 Jun 2024(m)-0.15(m)(m)
1 Jan 202431 Mar 2024(m)-1.35(m)(m)
1 Apr 202330 Jun 2023(m)-1.16(m)(m)
1 Jan 202331 Mar 2023(m)-1.74(m)(m)
1 Oct 202231 Dec 2022(m)-0.08(m)(m)

30 Sept 2025 ○ Estimate (m) ● Actual -1.09

-55.88-41.98-28.08-14.19-0.2930 Sept 2021: estimate (m); actual -0.4730 Sept 2021(m)30 Sept 2022: estimate (m); actual -55.8030 Sept 2022(m)30 Sept 2023: estimate (m); actual -13.3230 Sept 2023(m)30 Sept 2024: estimate (m); actual -14.2930 Sept 2024(m)30 Sept 2025: estimate (m); actual -1.0930 Sept 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Oct 202430 Sept 2025(m)-1.09(m)(m)
1 Oct 202330 Sept 2024(m)-14.29(m)(m)
1 Oct 202230 Sept 2023(m)-13.32(m)(m)
1 Oct 202130 Sept 2022(m)-55.80(m)(m)
1 Oct 202030 Sept 2021(m)-0.47(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 5.55M ■ Earnings -1.13M — Profit margin -20.30%

-1.94M-21.3%0.86M-15.7%3.65M-10.2%6.45M-4.6%30 Jun 2025: revenue 4.61M; earnings -0.90M; profit margin -19.43%30 Jun 202531 Dec 2025: revenue 5.02M; earnings -0.28M; profit margin -5.64%31 Dec 202531 Mar 2026: revenue 5.64M; earnings -0.80M; profit margin -14.15%31 Mar 202630 Jun 2026: revenue 5.55M; earnings -1.13M; profit margin -20.30%30 Jun 2026

30 Sept 2025 ■ Revenue 19.19M ■ Earnings -2.04M — Profit margin -10.63%

-82.74M-199.0%-39.14M-135.9%4.46M-72.7%48.06M-9.6%30 Sept 2022: revenue 35.40M; earnings -70.08M; profit margin -197.96%30 Sept 202230 Sept 2023: revenue 24.16M; earnings -22.94M; profit margin -94.96%30 Sept 202330 Sept 2024: revenue 19.48M; earnings -3.70M; profit margin -18.99%30 Sept 202430 Sept 2025: revenue 19.19M; earnings -2.04M; profit margin -10.63%30 Sept 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$0.47(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$0.47High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning YCBD

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-13; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-2.89M
Profit margin
-13.80%
Return on assets · 12 month
-25.07%
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
154.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
988.13K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-6.20%*
Total return · month
-6.20%*
Total return · quarter
-32.60%*
Total return · half year
-34.47%*
Total return · year to date
-65.05%*
Total return · 1 year
-65.81%*
Total return · 3 years
-94.30%*
Total return · 5 years
-99.93%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$20.93M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

cbdMD, Inc. Overview

View more →

(m)

(m)

SEC CIK
1644903
Industry (SIC)
2844 Perfumes, Cosmetics & Other Toilet Preparations
Country of operation
United States
Business address
8845 RED OAK BOULEVARD, CHARLOTTE, North Carolina, 28217, United States
Fiscal year end
0930
Phone
704-445-3060

Similar stocks

Stock NameCountryMarket CapPE Ratio
BONK, INC. (BNKK)United States$0.011B-0.14
Caring Brands, Inc. (CABR)United States$0.013B
UNITED GUARDIAN INC (UG)United States$0.034B13.30
Axil Brands, Inc. (AXIL)United States$0.042B17.24
SOLESENCE, INC. (SLSN)United States$0.058B-25.13
EDGEWELL PERSONAL CARE Co (EPC)United States$1.261B-13.27
COTY INC. (COTY)United States$2.307B-3.15
INTERPARFUMS INC (IPAR)United States$3.707B21.36
e.l.f. Beauty, Inc. (ELF)United States$5.934B
Kenvue Inc. (KVUE)United States$33.844B22.14